40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Analysts expect the stock price to increase by 27.11%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
9.39B
The estimated revenue has increased from the previous period.
1.88B
The estimated EBITDA has increased from the previous period.
4.50
The estimated EPS has decreased from the previous period.
1.21B
The estimated net income has decreased from the previous period.
-28.33M
The estimated EBIT has decreased from the previous period.
1.63B
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
17.93B
Revenue has decreased from the previous period.
14.39%
Revenue growth rate has decreased from the previous period.
3.71B
EBITDA has decreased from the previous period.
20.72%
EBITDA margin has increased from the previous period.
272.50M
EBIT has increased from the previous period.
1.52%
EBIT margin has increased from the previous period.
3.44B
Depreciation has decreased from the previous period.
105.55M
Total cash has decreased from the previous period.
0.59%
Cash percentage has decreased from the previous period.
2.38B
Receivables have decreased from the previous period.
13.27%
Receivables percentage has decreased from the previous period.
17.28M
Inventories have decreased from the previous period.
0.10%
Inventory percentage has decreased from the previous period.
809.04M
Accounts payable has decreased from the previous period.
4.51%
Payables percentage has decreased from the previous period.
-4.00B
Capital expenditure has decreased from the previous period.
-22.33%
CapEx percentage has decreased from the previous period.
8.16%
WACC has decreased from the previous period.
9.50%
Cost of equity has decreased from the previous period.
6.55%
Cost of debt has increased from the previous period.
1.15
Beta has decreased from the previous period.
267.40M
Diluted shares outstanding has increased from the previous period.
6.29B
Total debt has decreased from the previous period.
9.59B
Total equity has decreased from the previous period.
15.88B
Total capital has decreased from the previous period.
39.62%
Debt weighting has decreased from the previous period.
60.38%
Equity weighting has increased from the previous period.
254.15M
EBIAT has increased from the previous period.
-507.05M
UFCF has increased from the previous period.
0.50%
Long-term growth rate is unchanged from the previous period.
-6.65B
Terminal value has increased from the previous period.
-6.15B
Enterprise value has increased from the previous period.
6.25B
Net debt has decreased from the previous period.
-12.40B
Equity value has increased from the previous period.
-46.36
Equity value per share has increased from the previous period.
